Article: Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitlePrevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
AuthorsLi, PK1
Kwan, BC1
Leung, CB1
Kwan, TH1
Wong, KM1
Lui, SL1
Tsang, WK1
Mak, CC1
Mak, SK1
Yu, AW1
Tang, S1
Issue Date2005
CitationKidney International. Supplement, 2005 n. 94, p. S36-40 [How to Cite?]
AbstractBACKGROUND: End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions. METHODS: From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose. RESULTS: There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently "healthy" (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (> or =1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP> or =140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure. CONCLUSION: It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.
ISSN0098-6577
2011 SCImago Journal Rankings: 0.103
DC Field
Value
dc.contributor.authorLi, PK
dc.contributor.authorKwan, BC
dc.contributor.authorLeung, CB
dc.contributor.authorKwan, TH
dc.contributor.authorWong, KM
dc.contributor.authorLui, SL
dc.contributor.authorTsang, WK
dc.contributor.authorMak, CC
dc.contributor.authorMak, SK
dc.contributor.authorYu, AW
dc.contributor.authorTang, S
dc.date.accessioned2012-09-05T05:23:46Z
dc.date.available2012-09-05T05:23:46Z
dc.date.issued2005
dc.description.abstractBACKGROUND: End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions. METHODS: From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose. RESULTS: There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently "healthy" (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (> or =1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP> or =140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure. CONCLUSION: It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationKidney International. Supplement, 2005 n. 94, p. S36-40 [How to Cite?]
dc.identifier.epage40
dc.identifier.issn0098-6577
2011 SCImago Journal Rankings: 0.103
dc.identifier.issue94
dc.identifier.pmid15752237
dc.identifier.scopuseid_2-s2.0-15944403516
dc.identifier.spageS36
dc.identifier.urihttp://hdl.handle.net/10722/162803
dc.languageeng
dc.publisher.placeUnited States
dc.relation.ispartofKidney international. Supplement
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 And Over
dc.subject.meshDiabetes Mellitus - Epidemiology
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshHong Kong - Epidemiology
dc.subject.meshHumans
dc.subject.meshHypertension, Renal - Epidemiology
dc.subject.meshKidney Diseases - Diagnosis - Epidemiology
dc.subject.meshMale
dc.subject.meshMass Screening
dc.subject.meshMiddle Aged
dc.subject.meshPrevalence
dc.subject.meshRisk Factors
dc.titlePrevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
dc.typeArticle
Author Affiliations
  1. Prince of Wales Hospital Hong Kong